Xilio Therapeutics, Inc.

NASDAQ:XLO

0.6998 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -15.844-13.265-13.093-14.02-13.925-17.203-17.655-16.748-19.355-22.646-22.466-19.79-24.613-21.353-19.701-16.251-23.181-16.667-20.772-14.819-0.012-0.008
Depreciation & Amortization 0.3810.4970.3750.3810.4450.4430.4490.460.4920.4990.4890.4730.4450.440.3940.3820.3730.350.3410.31600
Deferred Income Tax 000000-1.3380.0010.002000000.0040.1550.0480.015-0.3050.04600
Stock Based Compensation 1.3511.5351.5161.5741.5111.8330.0021.8611.81.7911.8151.8712.7092.0292.0711.0911.0020.7940.3660.68300
Change In Working Capital -2.69940.211-2.957-36.34831.9224.4261.8331.0340.4-4.9251.88-2.5224.65-2.0040.018-6.1391.582-7.2647.6243.2760.0030.003
Accounts Receivables 00000-300000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 2.112-0.591.602-0.2810.509-0.304-0.4380.542-0.809-1.3581.4570.245-0.397-0.82-1.192-3.5474.759-2.8382.5880.59700
Other Working Capital -4.81140.801-4.559-36.0671.41334.732.2710.4921.2091.3580.423-2.7670.005-1.1841.21-2.592-3.177-4.4265.0362.6790.0030.003
Other Non Cash Items 2.33400.00234.7411.89233.0223.2820.0230.0870.0310.0590.0590.0530.0530.0560.1980.0880.053-0.2640.0830-0
Operating Cash Flow -14.47728.978-14.157-13.67219.953-10.502-13.427-13.369-16.574-25.25-18.223-19.909-16.756-20.835-17.162-20.719-20.136-22.734-12.705-10.461-0.008-0.005
Investing Activities:
Investments In Property Plant And Equipment -0.401-0.022-0.006-0.009-0.021000-0.316-0.17-0.509-0.333-0.771-0.254-0.378-0.114-0.438-0.17-0.108-0.574-0.001-0.001
Acquisitions Net 0000000000000000000000
Purchases Of Investments 0000000000000000000000
Sales Maturities Of Investments 0000000000000000000000
Other Investing Activites 00000000001.72900000000000
Investing Cash Flow -0.401-0.022-0.006-0.009-0.021000-0.316-0.17-0.509-0.333-0.771-0.254-0.378-0.114-0.438-0.17-0.108-0.574-0.001-0.001
Financing Activities:
Debt Repayment 003.382-0.007-0.021-3.354-1.688-2.244-1.132-1.688-0.021-0.022-0.021-0.021-0.0220.287-0.354-0.021-0.028-0.07100
Common Stock Issued 47.3184.8270.0010.0042.5164.3080.0540.0080.1400000.016115.6230.9890.005144.9110000
Common Stock Repurchased 0000000.194000000000000000
Dividends Paid 0000000000000000000000
Other Financing Activities 0.0440.0054.819017.54800.0540.0080.1400000.016115.8480.0140.005144.9110.1530.00600.01
Financing Cash Flow 47.3624.8328.202-0.00320.0430.954-1.634-0.002-0.001-0.002-0.021-0.022-0.021-0.005115.8260.301-0.349144.890.125-0.06500.01
Other Information:
Effect Of Forex Changes On Cash 000000-23.193023.1930000000000000
Net Change In Cash 32.48433.788-5.961-13.68440.969-10.724-15.068-15.605-17.882-27.108-18.753-20.264-17.548-21.09498.286-20.532-20.923121.986-12.688-11.1-0.0090.004
Cash At End Of Period 123.34590.86157.07363.03474.94933.9844.70461.35276.95794.839121.947140.7160.964178.512199.606101.32121.852142.77520.78933.4770.0450.053